Biotechnology companies around the globe know Ferro Pfanstiehl Laboratories (FPL) as a reliable, commercial producer of rare and specialized carbohydrates / sugars. All of our cataloged products can be customized to meet your specific needs.

For example, FPL has developed several lines of High Purity, Low Endotoxin sugars for use in the area of Therapeutic Protein Biopharmaceutical Processing and Formulation:

1. High Purity Carbohydrates are used in mammalian cell culture growth media, to guard against microbial contamination.
    
2. High Purity and Low Endotoxin disaccharide sugars (Sucrose, Trehalose and Maltose) are used to stabilize therapeutic proteins and extend formulation shelf life.
    
3. Ferro Pfanstiehl's High Purity Low Endotoxin Mannitol is used as a bulking agent, to improve low dosage Therapeutic Protein drug formulation accuracy and to improve solubility characteristics.
    
4. High Purity and Low Endotoxin Sugars are used as processing aids, in the isolation and purification of human plasma derived proteins, in a process called "fractionation." Human plasma protein "Factor VIII" is isolated and purified in this manner and administered in injectable form for the treatment of Hemophilia. Factor VIII promotes blood clotting in Hemophilia patients who otherwise lack this critical blood-plasma component.

Utilizing FPL-purified disaccharide sugars for therapeutic protein Biopharmaceutical formulation is an economical means to assure regulatory compliance, consistent product stability, long shelf life and the highest purity Biopharmaceutical product formulations. Using Ferro Pfanstiehl's Disaccharide Sugars reduces the risk of contamination and the risk of experiencing undefined bioactivity-yield performance variability during process scale-up development, formulation development and commercial manufacturing.

To learn more about our injectable quality sugars, contact us or call 1-800-383-0126.